AFRY’s newly released Fossil Detox Report, unveiled during New York Climate Week, highlights the urgent need for a global ...

A new report by the Capgemini Research Institute, titled “A World in Balance 2024: Accelerating Sustainability Amidst ...

Interested in the spatial research landscape, technological breakthroughs and future directions? Check out this interview ...

RIT receives $9.6 million to advance quantum computing technologies with key partners through NORDTECH and Air Force Research ...

Rotterdam-based Nearfield Instruments was recently hailed by the press as a future billion-dollar company, but René ...

The adoption of QIAcuity digital PCR remains strong with more than 2,000 cumulative placements at the end of 2023 and citations in over 450 publications. Key customers include pharmaceutical and ...

STMicro has just announced the availability of the STM32C071 Arm Cortex-M0+ microcontroller part of the STM32C0 series with ...

Newcells Biotech (“Newcells”), a leading drug discovery partner specialising in the development of in vitro models and ...

About Fate Therapeutics, Inc. Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular ...

Fate Therapeutics (FATE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

By Pooja Toshniwal Paharia New AI-driven tool converts common histology images into detailed, multi-layered cancer markers, ...